APLS
Apellis Pharmaceuticals Inc
3.40$
-0.1%
vs. previous close
Closing price · As of: Aug 13, 2026
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.33 | 0.79 | 0.71 | 3.34 | 6.31 | 7.97 | |
| – | 0.00 | 0.00 | 0.00 | 3.66 | 2.35 | 0.01 | 0.33 | 0.06 | 0.05 | 0.49 | 0.95 | 0.81 | |
| – | 0.00 | 0.00 | 0.00 | -3.66 | -2.35 | -0.01 | 3.00 | 0.73 | 0.66 | 2.85 | 5.36 | 7.15 | |
| 0.51 | 0.46 | 0.76 | 1.27 | 2.91 | 1.94 | 3.55 | 3.99 | 4.99 | 3.65 | 2.99 | 2.64 | 2.35 | |
| 0.37 | 0.16 | 0.35 | 0.24 | 0.75 | 0.42 | 1.08 | 1.85 | 2.09 | 2.61 | 4.22 | 3.37 | 4.37 | |
| 0.88 | 0.62 | 1.11 | 1.51 | 3.66 | 2.35 | 4.62 | 5.84 | 7.08 | 6.26 | 7.21 | 6.69 | 6.71 | |
| -0.88 | -0.62 | -2.57 | -1.51 | -3.66 | -2.35 | -4.63 | -2.84 | -6.35 | -5.60 | -4.36 | -1.33 | 0.44 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 | 0.08 | 0.40 | 0.16 | 0.31 | 0.25 | 0.33 | 0.35 | |
| -0.86 | -0.62 | -2.57 | -1.50 | -3.68 | -2.34 | -4.90 | -4.56 | -8.84 | -6.14 | -4.44 | -1.59 | 0.19 | |
| – | -0.02 | -1.47 | -1.51 | 0.02 | -0.01 | 0.08 | 0.02 | 0.00 | 0.01 | 0.02 | 0.01 | 0.01 | |
| -0.86 | -0.60 | -2.57 | -1.50 | -3.68 | -2.34 | -4.90 | -4.59 | -8.84 | -6.15 | -4.45 | -1.60 | 0.18 | |
| -0.88 | -0.62 | 0.35 | -1.51 | -3.67 | -2.30 | -4.80 | -4.15 | -8.66 | -5.82 | -4.17 | -1.25 | 0.56 |
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.